CREG

CREG
Name	Cellular repressor of E1A-stimulated genes
Gene	CREG1
Organism	Homo sapiens
Uniprot	Q9HBW8

CREG

Overview

Cellular repressor of E1A-stimulated genes (CREG) is a small secreted glycoprotein implicated in the modulation of cell growth, differentiation, and intracellular trafficking. First characterized in studies involving Adenovirus E1A protein interactions and transcriptional regulation in HeLa and NIH 3T3 cells, CREG emerged alongside proteins studied in Virology and Molecular Biology as a factor that antagonizes viral oncoprotein function. Subsequent work linked CREG to pathways investigated in Developmental Biology and Cell Biology, including associations with endosomal machinery characterized in research from groups using models such as Drosophila melanogaster, Mus musculus, and human cell lines.

Molecular Structure and Function

CREG is encoded by the CREG1 gene and translates to a ~220 amino acid protein that undergoes signal peptide cleavage and N-linked glycosylation in the Endoplasmic Reticulum and Golgi apparatus. Structural studies using approaches like X-ray crystallography and NMR spectroscopy describe a compact fold related to family members involved in extracellular matrix interactions and receptor binding; CREG contains motifs that mediate binding to the mannose-6-phosphate/insulin-like growth factor II receptor system characterized in work on Mannose-6-phosphate receptor and Insulin-like growth factor II. Functional assays demonstrate that CREG modulates activity of transcriptional regulators identified in screens for E1A-responsive factors, influences signaling pathways such as those mediated by Transforming growth factor beta receptors and Mitogen-activated protein kinase cascades, and interacts with proteins of the Vacuolar protein sorting and Endosomal sorting complexes required for transport networks. Biochemical interaction partners reported in proteomics studies include components similar to those found in complexes studied in Saccharomyces cerevisiae and mammalian trafficking systems.

Expression and Regulation

CREG expression is developmentally regulated and tissue-specific, with notable expression in Placenta, Heart, Liver, and neuronal tissues studied in models like Rat and Mouse. Transcriptional control involves promoter elements responding to transcription factors characterized in genetic studies such as SP1, E2F family members, and regulators implicated in stress-responsive transcription associated with Hypoxia-inducible factor 1 targets. Post-translational regulation includes glycosylation sites conserved across vertebrates and cleavage events analogous to processing described for proteins handled by Furin and other proprotein convertases. MicroRNA-mediated regulation was inferred from datasets involving microRNAs characterized in miRBase and large-scale profiling performed in cell lines such as HEK293 and primary tissues examined in consortium projects like those led by ENCODE and GTEx.

Role in Development and Differentiation

Functional studies in developmental models indicate CREG participates in lineage specification and differentiation programs explored in systems including Embryonic stem cell cultures, Xenopus laevis embryogenesis assays, and mammalian organogenesis models. Overexpression and knockdown experiments in Mesenchymal stem cell and Neural progenitor cell cultures show effects on differentiation markers previously described in studies of cardiac and neuronal fate, overlapping with pathways regulated by factors like GATA4, NKX2-5, SOX2, and NEUROD1. In Drosophila models engineered to express vertebrate CREG orthologs, phenotypic analyses parallel research themes from classical developmental genetics involving Homeotic genes and signaling centers such as those governed by Wingless and Hedgehog orthologues. CREG has been reported to modulate apoptosis and senescence programs in cultured fibroblasts, linking it to molecular effectors characterized in cell death research such as p53 and BCL2 family members.

Clinical Significance and Disease Associations

Altered CREG expression has been observed in pathological contexts examined in clinical and translational studies of Cardiovascular disease, Cancer, and Fibrosis. In oncology datasets from cohorts including samples profiled in studies of Breast cancer, Colorectal cancer, and Hepatocellular carcinoma, CREG differential expression correlates variably with tumor suppressor or tumor-promoting signatures depending on cellular context and co-occurring genetic alterations such as mutations in TP53, KRAS, or PIK3CA. In cardiovascular research, CREG modulation influences responses to injury in models of Myocardial infarction and vascular remodeling studied with techniques described in Echocardiography and histopathology reports. Associations with lysosomal and trafficking disorders intersect with literature on Lysosomal storage disease pathways and receptors such as the mannose-6-phosphate receptor characterized in inherited disease studies. Clinical biomarker analyses have been reported in patient cohorts assembled in biobanks affiliated with institutions like NIH and multicenter consortia.

Experimental Methods and Research Tools

Investigations of CREG employ molecular cloning, gene editing using CRISPR-Cas9, RNA interference with siRNA or shRNA vectors, and overexpression systems in cell lines such as HEK293T and HeLa. Protein characterization uses glycoprotein analysis methods including PNGase F treatment, lectin blotting, and mass spectrometry techniques pioneered in proteomics centers. Subcellular localization and trafficking studies use confocal microscopy with markers for Early endosome antigen 1 and lysosomal markers used in imaging cores at universities and research institutes. Animal models include transgenic and knockout mice generated using strategies described by The Jackson Laboratory and phenotyped with assays established in developmental biology core facilities. High-throughput interactomics and transcriptomics datasets integrating techniques from RNA-seq, chromatin immunoprecipitation sequencings developed by consortia like ENCODE, and proximity labeling approaches are applied to map CREG networks.

Category:Proteins